Skip to main content
. 2024 May 10;15:1398927. doi: 10.3389/fimmu.2024.1398927
SINE Selectively Inhibits Nuclear Export
XPO1 Exportin 1
COVID-19 Coronavirus Disease 2019
DMD Duchenne muscular dystrophy
DDR DNA damage response
STORM Selinexor Treatment with Refractory Myeloma
BOSTON Bortezomib, Selinexor, and Dexamethasone in Patients with Multiple Myeloma
SADAL Selinexor in patients with relapsed or refractory diffuse large B-cell lymphom
NHL Non-Hodgkin’s Lymphoma
AML Acute Myeloid Leukemia
CLL Chronic lymphocytic leukemia
STS Soft Tissue Sarcoma
NK Natural Killer
HLA-E Human Leukocyte Antigen E
NF-kB Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B cells
IκBα Inhibitor of NF-kB alpha
STAT3 Signal Transducer and Activator of Transcription 3
NETs Neutrophil Extracellular Traps
ADAR1-p150 Adenosine Deaminase Acting on RNA 1, p150 isoform
LPS lipopolysaccharide
RSV respiratory syncytial virus
HMGB1 High Mobility Group Box 1
MHV mouse hepatitis virus
FLAG-Ida Fludarabine, Cytarabine, Granulocyte colony-stimulating factor (G-CSF), and Idarubicin
ALT Alanine Transaminase
CRISPR-Cas9 Clustered Regularly Interspaced Short Palindromic Repeats” and “CRISPR associated protein 9
ASB8 Ankyrin Repeat and SOCS Box Containing 8
TGFβ-SMAD4 Transforming Growth Factor Beta-SMAD Family Member 4 Pathway
WNT10A Wnt Family Member 10A
DUSP1 Dual Specificity Phosphatase 1
ETV7 ETS Variant Transcription Factor 7
ABCC4 ATP-binding cassette subfamily C member 4
WGCNA weighted gene co-expression network analysis
NFATc1 Nuclear Factor of Activated T Cells 1
PD Parkinson’s Disease
NLRP3 NLR Family Pyrin Domain Containing 3
CAVD calcific aortic valve disease